NIH-funded research R03 grant

Understanding how certain bacteria can kill harmful pathogens

Official title: Identifying the genetic basis of strain specific antimicrobial activity against a major foodborne pathogen

Funded at University of Arizona · NIH-10993161 · Data updated 2026-11-12

This study is looking at how certain bacteria can make natural substances that fight off germs that cause foodborne illnesses, and it’s for anyone interested in understanding how we can better protect our health from harmful bacteria.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startDecember 1, 2023
Project endOctober 31, 2025
Funding year2025
Award (this year)$74,448
NIH project number5R03AI180493-02
Project IDNIH-10993161 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are at risk of foodborne illnesses or have conditions related to bacterial infections.

Less likely to help

Patients with viral infections or those not affected by foodborne pathogens may not benefit from this research.

What this research studies

This research investigates the genetic factors that enable specific strains of bacteria to produce antimicrobial substances that can target and kill harmful pathogens, particularly those that cause foodborne illnesses. By studying the interactions between these bacteria and their environment, the researchers aim to identify the molecules responsible for this antimicrobial activity. The project will involve laboratory experiments to characterize these substances and their effectiveness against various bacterial strains, including those that affect human health.

Why it matters

Potential benefit: If successful, this research could lead to new, effective treatments for bacterial infections, particularly those related to foodborne pathogens.

How similar studies have gone: Previous research has shown promise in using bacteriocins and similar antimicrobial agents to combat bacterial infections, indicating a potential for success in this approach.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Baltrus, David a — University of Arizona
  • Study coordinator: Baltrus, David a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.